3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
6
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Breast Neoplasms
9
Prostatic Neoplasms
6
Melanoma
6
Colorectal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Neoplasm Metastasis
4
Multiple Myeloma
4
Mouth Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Neoplasms
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Dysplasia
2
Skin Neoplasms
2
Sarcoma, Kaposi
2
Sarcoma
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Inflammatory Breast Neoplasms
2
HIV Infections
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Urinary Bladder Diseases
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Turcot syndrome
1
Thrombocytosis
1
Interventions
Cyclophosphamide
48
fludarabine phosphate
36
Methotrexate
26
Cytarabine
24
fludarabine
23
Whole-Body Irradiation
23
Rituximab
19
Cyclosporine
19
Antilymphocyte Serum
18
Peripheral Blood Stem Cell Transplantation
17
Filgrastim
17
Busulfan
17
Mycophenolic Acid
16
Tacrolimus
15
Azacitidine
15
Alemtuzumab
15
Radiotherapy
13
Melphalan
13
Imatinib Mesylate
13
Etoposide
13
Vincristine
11
Methylprednisolone
11
Cord Blood Stem Cell Transplantation
11
Dexamethasone
10
venetoclax
8
Granulocyte Colony-Stimulating Factor
8
Clofarabine
8
thymoglobulin
7
sargramostim
7
nilotinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Leukemia
×
Biopsy
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled